These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

291 related articles for article (PubMed ID: 15170592)

  • 1. Selective human enterovirus and rhinovirus inhibitors: An overview of capsid-binding and protease-inhibiting molecules.
    Shih SR; Chen SJ; Hakimelahi GH; Liu HJ; Tseng CT; Shia KS
    Med Res Rev; 2004 Jul; 24(4):449-74. PubMed ID: 15170592
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The efficacy of viral capsid inhibitors in human enterovirus infection and associated diseases.
    Li C; Wang H; Shih SR; Chen TC; Li ML
    Curr Med Chem; 2007; 14(8):847-56. PubMed ID: 17430140
    [TBL] [Abstract][Full Text] [Related]  

  • 3. In vitro activity of pirodavir (R 77975), a substituted phenoxy-pyridazinamine with broad-spectrum antipicornaviral activity.
    Andries K; Dewindt B; Snoeks J; Willebrords R; van Eemeren K; Stokbroekx R; Janssen PA
    Antimicrob Agents Chemother; 1992 Jan; 36(1):100-7. PubMed ID: 1317142
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Combating enterovirus replication: state-of-the-art on antiviral research.
    Thibaut HJ; De Palma AM; Neyts J
    Biochem Pharmacol; 2012 Jan; 83(2):185-92. PubMed ID: 21889497
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Cryo-EM structure of pleconaril-resistant rhinovirus-B5 complexed to the antiviral OBR-5-340 reveals unexpected binding site.
    Wald J; Pasin M; Richter M; Walther C; Mathai N; Kirchmair J; Makarov VA; Goessweiner-Mohr N; Marlovits TC; Zanella I; Real-Hohn A; Verdaguer N; Blaas D; Schmidtke M
    Proc Natl Acad Sci U S A; 2019 Sep; 116(38):19109-19115. PubMed ID: 31462495
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Inhibitory antibodies identify unique sites of therapeutic vulnerability in rhinovirus and other enteroviruses.
    Meng B; Lan K; Xie J; Lerner RA; Wilson IA; Yang B
    Proc Natl Acad Sci U S A; 2020 Jun; 117(24):13499-13508. PubMed ID: 32467165
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Conservation of amino acids in human rhinovirus 3C protease correlates with broad-spectrum antiviral activity of rupintrivir, a novel human rhinovirus 3C protease inhibitor.
    Binford SL; Maldonado F; Brothers MA; Weady PT; Zalman LS; Meador JW; Matthews DA; Patick AK
    Antimicrob Agents Chemother; 2005 Feb; 49(2):619-26. PubMed ID: 15673742
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Back to the future: Advances in development of broad-spectrum capsid-binding inhibitors of enteroviruses.
    Egorova A; Ekins S; Schmidtke M; Makarov V
    Eur J Med Chem; 2019 Sep; 178():606-622. PubMed ID: 31226653
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Direct-acting antivirals and host-targeting strategies to combat enterovirus infections.
    Bauer L; Lyoo H; van der Schaar HM; Strating JR; van Kuppeveld FJ
    Curr Opin Virol; 2017 Jun; 24():1-8. PubMed ID: 28411509
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Rhinovirus Inhibitors: Including a New Target, the Viral RNA.
    Real-Hohn A; Blaas D
    Viruses; 2021 Sep; 13(9):. PubMed ID: 34578365
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VP1 sequencing of all human rhinovirus serotypes: insights into genus phylogeny and susceptibility to antiviral capsid-binding compounds.
    Ledford RM; Patel NR; Demenczuk TM; Watanyar A; Herbertz T; Collett MS; Pevear DC
    J Virol; 2004 Apr; 78(7):3663-74. PubMed ID: 15016887
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Rhinovirus chemotherapy.
    Patick AK
    Antiviral Res; 2006 Sep; 71(2-3):391-6. PubMed ID: 16675037
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The structure of antiviral agents that inhibit uncoating when complexed with viral capsids.
    Rossmann MG
    Antiviral Res; 1989 Feb; 11(1):3-13. PubMed ID: 2540708
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Phenylpropenoids from Bupleurum fruticosum as Anti-Human Rhinovirus Species A Selective Capsid Binders.
    Fois B; Bianco G; Sonar VP; Distinto S; Maccioni E; Meleddu R; Melis C; Marras L; Pompei R; Floris C; Caboni P; Cottiglia F
    J Nat Prod; 2017 Oct; 80(10):2799-2806. PubMed ID: 29039946
    [TBL] [Abstract][Full Text] [Related]  

  • 15. A novel druggable interprotomer pocket in the capsid of rhino- and enteroviruses.
    Abdelnabi R; Geraets JA; Ma Y; Mirabelli C; Flatt JW; Domanska A; Delang L; Jochmans D; Kumar TA; Jayaprakash V; Sinha BN; Leyssen P; Butcher SJ; Neyts J
    PLoS Biol; 2019 Jun; 17(6):e3000281. PubMed ID: 31185007
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Antiviral therapy for enteroviruses and rhinoviruses.
    Rotbart HA
    Antivir Chem Chemother; 2000 Jul; 11(4):261-71. PubMed ID: 10950388
    [TBL] [Abstract][Full Text] [Related]  

  • 17. The enterovirus 3C protease inhibitor SG85 efficiently blocks rhinovirus replication and is not cross-resistant with rupintrivir.
    Lacroix C; George S; Leyssen P; Hilgenfeld R; Neyts J
    Antimicrob Agents Chemother; 2015 Sep; 59(9):5814-8. PubMed ID: 26055377
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Recent advances in rhinovirus therapeutics.
    Charles CH; Yelmene M; Luo GX
    Curr Drug Targets Infect Disord; 2004 Dec; 4(4):331-7. PubMed ID: 15578974
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SDZ 35-682, a new picornavirus capsid-binding agent with potent antiviral activity.
    Rosenwirth B; Oren DA; Arnold E; Kis ZL; Eggers HJ
    Antiviral Res; 1995 Jan; 26(1):65-82. PubMed ID: 7741522
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In vitro characterisation of a pleconaril/pirodavir-like compound with potent activity against rhinoviruses.
    Lacroix C; Laconi S; Angius F; Coluccia A; Silvestri R; Pompei R; Neyts J; Leyssen P
    Virol J; 2015 Jul; 12():106. PubMed ID: 26169596
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.